Details for New Drug Application (NDA): 050007
✉ Email this page to a colleague
NDA 050007 describes VIBRAMYCIN, which is a drug marketed by Pfizer and is included in four NDAs. Additional details are available on the VIBRAMYCIN profile page.
The generic ingredient in VIBRAMYCIN is doxycycline calcium. There are three drug master file entries for this compound. Additional details are available on the doxycycline calcium profile page.
The generic ingredient in VIBRAMYCIN is doxycycline calcium. There are three drug master file entries for this compound. Additional details are available on the doxycycline calcium profile page.
Summary for 050007
| Tradename: | VIBRAMYCIN |
| Applicant: | Pfizer |
| Ingredient: | doxycycline hyclate |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | EQ 50MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | Yes | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | EQ 100MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
